You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Moodys
Mallinckrodt
Harvard Business School
Colorcon

Last Updated: January 21, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Sonazoid

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Sonazoid?

Sonazoid is an investigational drug.

There have been 11 clinical trials for Sonazoid. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2015.

The most common disease conditions in clinical trials are Focal Nodular Hyperplasia, Breast Neoplasms, and Liver Diseases. The leading clinical trial sponsors are GE Healthcare, Thomas Jefferson University, and National Cancer Institute (NCI).

There are eight hundred and forty-five US patents protecting this investigational drug and seven international patents.

Recent Clinical Trials for Sonazoid
TitleSponsorPhase
Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCCSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 3
Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal CancerNational Cancer Institute (NCI)Early Phase 1
Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal CancerSidney Kimmel Cancer Center at Thomas Jefferson UniversityEarly Phase 1

See all Sonazoid clinical trials

Clinical Trial Summary for Sonazoid

Top disease conditions for Sonazoid
Top clinical trial sponsors for Sonazoid

See all Sonazoid clinical trials

US Patents for Sonazoid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sonazoid   Start Trial Perfluoroalkanes and perfluoroalkane and sulphur hexafluoride compositions as aerosol propellants   Start Trial
Sonazoid   Start Trial Polycarbonate of alkyl cyclohexylidene bisphenol Bayer Aktiengesellschaft (Leverkusen, DE)   Start Trial
Sonazoid   Start Trial Tight binding of proteins to surfaces Washington Research Foundation (Seattle, WA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Moodys
Mallinckrodt
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.